Correction to: Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan
In the original publication of the article, two sentences in the “Results” section were published incorrectly. The corrected texts are provided below:
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research
More News: Aranesp | Chronic Kidney Disease | Dialysis | Japan Health | Marketing | Study | Urology & Nephrology